Cargando…

Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy

PURPOSE: DNA mismatch repair (MMR) is a highly conserved biological pathway that plays a key role in maintaining genomic stability. MMR has been reported as a prognostic marker in certain cancers; however, the results are controversial. Therefore, identification of the prognostic value of MMR genes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Chuchu, Li, Saisai, Zhao, Menghuang, Zhu, Haiyan, Zhu, Xueqiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Gynecologic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762798/ https://www.ncbi.nlm.nih.gov/pubmed/29063235 http://dx.doi.org/10.1007/s00404-017-4563-x

Ejemplares similares

The prognostic values of signal transducers activators of transcription family in ovarian cancer
por: Li, Saisai, et al.
Publicado: (2017)

Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis
por: Luo, Hui, et al.
Publicado: (2017)

Prognostic values of transketolase family genes in ovarian cancer
por: Zhao, Menghuang, et al.
Publicado: (2019)

Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis
por: Shen, Zhaojun, et al.
Publicado: (2017)

The prognostic values of the peroxiredoxins family in ovarian cancer
por: Li, Saisai, et al.
Publicado: (2018)

A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer
por: Pignata, Sandro, et al.
Publicado: (2021)

Incidence and predictors for chemotherapy modifications and their impact on the outcome of ovarian cancer patients
por: Hatsy, Sandra, et al.
Publicado: (2022)

Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies
por: Hu, Xiaoli, et al.
Publicado: (2017)

The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer
por: Chen, Fangfang, et al.
Publicado: (2021)

Prognostic values of aquaporins mRNA expression in human ovarian cancer
por: Chetry, Mandika, et al.
Publicado: (2018)

The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer
por: Rawert, Friederike Luise, et al.
Publicado: (2022)

Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer
por: Sznurkowski, Jacek J., et al.
Publicado: (2012)

CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer
por: Lin, Yun, et al.
Publicado: (2021)

Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer
por: von Au, Alexandra, et al.
Publicado: (2022)

Improving ovarian cancer imaging with LHRH-NBs: an experimental study
por: Li, Wenjuan, et al.
Publicado: (2016)

Predictive Value of HE4 in Platinum-Based Chemotherapy for Ovarian Cancer: A Systematic Review
por: Han, Yue, et al.
Publicado: (2021)

Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases
por: Di Giorgio, Angelo, et al.
Publicado: (2016)

Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score
por: Seebacher, Veronika, et al.
Publicado: (2018)

Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis
por: Ni, Liwei, et al.
Publicado: (2019)

Nomogram for predicting postoperative cancer-specific early death in patients with epithelial ovarian cancer based on the SEER database: a large cohort study
por: Zhang, Tingting, et al.
Publicado: (2021)

Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational study
por: Turan, Hasan, et al.
Publicado: (2022)

Evaluation of selected ultrasonographic parameters and marker levels in the preoperative differentiation of borderline ovarian tumors and ovarian cancers
por: Sobiczewski, Piotr, et al.
Publicado: (2012)

Cytoreductive Surgery Under Aminolevulinic Acid-Mediated Photodynamic Diagnosis Plus Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Ovarian Cancer and Primary Peritoneal Carcinoma: Results of a Phase I Trial
por: Liu, Yang, et al.
Publicado: (2014)

A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction
por: Zhao, Menghuang, et al.
Publicado: (2020)

Prognostic significance of bone only metastasis compared to visceral metastasis in patients with carcinoma cervix treated with platinum-based chemotherapy
por: Mallekavu, Suresh Babu, et al.
Publicado: (2017)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
por: Liu, Yixin, et al.
Publicado: (2019)

Chemical composition of surgical smoke produced during the loop electrosurgical excision procedure when treating cervical intraepithelial neoplasia
por: Liu, Yi, et al.
Publicado: (2021)

The sL1CAM in sera of patients with endometrial and ovarian cancers
por: Wojciechowski, Michał, et al.
Publicado: (2016)

Role of integrins in the metastatic spread of high-grade serous ovarian cancer
por: Krajnak, Slavomir, et al.
Publicado: (2021)

Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients
por: Müller, Carolin, et al.
Publicado: (2020)

Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
por: Müller, Carolin, et al.
Publicado: (2021)

Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue
por: Peters, Inge T. A., et al.
Publicado: (2016)

Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
por: Bieg, Dominik, et al.
Publicado: (2018)

Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2020)

Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma
por: Fujiwara, Kazuko, et al.
Publicado: (2011)

Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors
por: Wang, Lifei, et al.
Publicado: (2022)

Galectin-8 and -9 as prognostic factors for cervical cancer
por: Beyer, Susanne, et al.
Publicado: (2022)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer
por: Cornali, Tommaso, et al.
Publicado: (2017)

Usefulness of the HE4 biomarker as a second-line test in the assessment of suspicious ovarian tumors
por: Moszynski, Rafal, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u8s549nokv636lns54v2ijq8h1